We are live on ! Find out more
EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

176 hedge funds and large institutions have $802M invested in Eagle Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 73 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more call options, than puts

Call options by funds: $15.4M | Put options by funds: $5.04M

7% more capital invested

Capital invested by funds: $751M → $802M (+$51.2M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 17

4% less funds holding

Funds holding: 183 → 176 (-7)

25% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 73

Holders
176
Holders Change
-7
Holders Change %
-3.83%
% of All Funds
3.47%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
16
Increased
55
Reduced
73
Closed
17
Calls
$15.4M
Puts
$5.04M
Net Calls
+$10.4M
Net Calls Change
+$8.16M

Top Buyers

Rank Fund Capital Flow
1
WG
Winton Group
United Kingdom
+$8.82M
2
Renaissance Technologies
Renaissance Technologies
New York
+$7.18M
3
BlackRock
BlackRock
New York
+$4.93M
4
PWAM
Park West Asset Management
California
+$4.69M
5
Goldman Sachs
Goldman Sachs
New York
+$4.19M

Top Sellers

Rank Fund Capital Flow
1
HEC
Hudson Executive Capital
New York
-$8.85M
2
LSV Asset Management
LSV Asset Management
Illinois
-$5.51M
3
MCM
Matarin Capital Management
New York
-$4.45M
4
Marshall Wace
Marshall Wace
United Kingdom
-$2.92M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
OA
76
Oak Associates
Ohio
$1.21M – – –
New York State Teachers Retirement System (NYSTRS)
77
New York State Teachers Retirement System (NYSTRS)
New York
$1.16M +$574K +9,631 +100%
USGIU
78
U.S. Global Investors (USGI)
Texas
$1.13M +$1.12M +18,800 New
GC
79
Globeflex Capital
California
$1.13M +$589K +9,873 +111%
Truist Financial
80
Truist Financial
North Carolina
$1.1M +$1.1M +18,377 New
Bessemer Group
81
Bessemer Group
New Jersey
$1.09M +$1.01M +17,000 +1,545%
Deutsche Bank
82
Deutsche Bank
Germany
$1.08M +$78.4K +1,314 +8%
Rafferty Asset Management
83
Rafferty Asset Management
New York
$970K -$469K -7,858 -33%
IA
84
IndexIQ Advisors
New York
$965K -$304K -5,098 -24%
T. Rowe Price Associates
85
T. Rowe Price Associates
Maryland
$948K +$29.8K +500 +3%
KBC Group
86
KBC Group
Belgium
$909K – – –
HTC
87
Hershey Trust Company
Pennsylvania
$907K – – –
State of Wisconsin Investment Board
88
State of Wisconsin Investment Board
Wisconsin
$865K – – –
Fisher Asset Management
89
Fisher Asset Management
Washington
$861K -$209K -3,507 -20%
CEP
90
Chicago Equity Partners
Illinois
$849K -$1.3M -21,740 -61%
California State Teachers Retirement System (CalSTRS)
91
California State Teachers Retirement System (CalSTRS)
California
$835K -$22.8K -382 -3%
VOYA Investment Management
92
VOYA Investment Management
Georgia
$807K +$8.05K +135 +1%
Canada Life
93
Canada Life
Manitoba, Canada
$754K +$755K +12,658 New
SEI Investments
94
SEI Investments
Pennsylvania
$731K -$76K -1,274 -9%
HW
95
Hancock Whitney
Mississippi
$724K +$177K +2,976 +33%
Ensign Peak Advisors
96
Ensign Peak Advisors
Utah
$710K +$705K +11,817 New
Victory Capital Management
97
Victory Capital Management
Texas
$696K +$288K +4,828 +71%
SO
98
STRS Ohio
Ohio
$684K -$11.9K -200 -2%
OAM
99
Oxford Asset Management
United Kingdom
$653K -$1.25M -21,012 -66%
SFM
100
Systematic Financial Management
New Jersey
$634K +$61.1K +1,025 +11%
2 3
4
5 6

EGRX Hedge Fund Activity: Q4 2019 in Review

176 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Eagle Pharmaceuticals, Inc. (EGRX) for Q4 2019, worth a combined $802M — up 6.8% from $751M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of EGRX and 16 opened new positions — a net loss of 1 holder — while 73 trimmed existing stakes and 55 added.

The largest buyer was Winton Group, adding an estimated $8.82M. The largest seller was Hudson Executive Capital, cutting an estimated $8.85M.

  • 176 institutional investors held Eagle Pharmaceuticals, Inc. (EGRX) as of Q4 2019, down from 183 in Q3 2019.
  • Funds reported $802M of Eagle Pharmaceuticals, Inc. stock for Q4 2019, up 6.8% quarter-over-quarter.
  • 16 funds opened new Eagle Pharmaceuticals, Inc. positions in Q4 2019 and 17 closed out, a net change of -1 holder.
  • The largest Eagle Pharmaceuticals, Inc. buyer in Q4 2019 was Winton Group, an estimated $8.82M added.
  • The largest Eagle Pharmaceuticals, Inc. seller in Q4 2019 was Hudson Executive Capital, an estimated $8.85M sold.

Based on aggregated 13F filings for Q4 2019.